---
title: "Clearmind Medicine partners to develop intranasal MEAI for addiction & CNS disorders, boosting bioavailability & clinical progress."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275130893.md"
description: "Partnership established to improve absorption and aid in the progression of Clearmind's primary MEAI drug for addiction and other central nervous system conditions."
datetime: "2026-02-06T12:56:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275130893.md)
  - [en](https://longbridge.com/en/news/275130893.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275130893.md)
---

# Clearmind Medicine partners to develop intranasal MEAI for addiction & CNS disorders, boosting bioavailability & clinical progress.

Partnership established to improve absorption and aid in the progression of Clearmind's primary MEAI drug for addiction and other central nervous system conditions.

### Related Stocks

- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [MNMD.US](https://longbridge.com/en/quote/MNMD.US.md)
- [CMND.US](https://longbridge.com/en/quote/CMND.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PRME.US](https://longbridge.com/en/quote/PRME.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md)
- [Clearmind reports positive safety, tolerability in CMND-100 Phase I/II trial Part A dose escalation](https://longbridge.com/en/news/294366720.md)
- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)
- [IT Sector Accounts for Nearly One Third of U.S. Securities Litigation Risk in 1H 2026](https://longbridge.com/en/news/294507902.md)
- [Biotech experts want FDA drug reviews based on science, not politics](https://longbridge.com/en/news/293453841.md)